Christophe Fruchart

4.9k total citations
49 papers, 1.5k citations indexed

About

Christophe Fruchart is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Christophe Fruchart has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pathology and Forensic Medicine, 24 papers in Genetics and 15 papers in Oncology. Recurrent topics in Christophe Fruchart's work include Lymphoma Diagnosis and Treatment (35 papers), Chronic Lymphocytic Leukemia Research (22 papers) and CNS Lymphoma Diagnosis and Treatment (9 papers). Christophe Fruchart is often cited by papers focused on Lymphoma Diagnosis and Treatment (35 papers), Chronic Lymphocytic Leukemia Research (22 papers) and CNS Lymphoma Diagnosis and Treatment (9 papers). Christophe Fruchart collaborates with scholars based in France, Belgium and Luxembourg. Christophe Fruchart's co-authors include Hervé Tilly, Christian Bastard, Nicole Smadja, Dominique Leroux, Christophe Brigaudeau, Corinne Haïoun, Nicolas Aide, Charline Lasnon, Catherine Thiéblemont and Serge Bologna and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Christophe Fruchart

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christophe Fruchart France	19	930	610	402	368	336	49	1.5k
Deok‐Hwan Yang South Korea	22	688 0.7×	727 1.2×	455 1.1×	252 0.7×	397 1.2×	112	1.6k
J. M. Vose United States	15	801 0.9×	596 1.0×	243 0.6×	289 0.8×	107 0.3×	34	1.2k
Anne Lennard United Kingdom	20	831 0.9×	561 0.9×	414 1.0×	562 1.5×	218 0.6×	51	1.6k
G. Lepeu France	10	1.2k 1.3×	775 1.3×	245 0.6×	661 1.8×	209 0.6×	27	1.7k
Surender Juneja Australia	20	541 0.6×	375 0.6×	489 1.2×	538 1.5×	288 0.9×	85	1.3k
Giuseppe Gritti Italy	17	628 0.7×	651 1.1×	138 0.3×	298 0.8×	131 0.4×	59	1.2k
Ilse Christiansen Denmark	14	438 0.5×	227 0.4×	152 0.4×	229 0.6×	192 0.6×	31	789
Kamel Laribi France	17	329 0.4×	606 1.0×	604 1.5×	321 0.9×	336 1.0×	62	1.2k
Bernard Lenormand France	20	949 1.0×	512 0.8×	355 0.9×	638 1.7×	211 0.6×	52	1.6k
Charles Herbaux France	23	1.2k 1.2×	675 1.1×	460 1.1×	1.1k 3.0×	307 0.9×	111	1.9k

Countries citing papers authored by Christophe Fruchart

Since Specialization

Citations

This map shows the geographic impact of Christophe Fruchart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Fruchart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Fruchart more than expected).

Fields of papers citing papers by Christophe Fruchart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Fruchart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Fruchart. The network helps show where Christophe Fruchart may publish in the future.

Co-authorship network of co-authors of Christophe Fruchart

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Fruchart. A scholar is included among the top collaborators of Christophe Fruchart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Fruchart. Christophe Fruchart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Camus, Vincent, Aurélien Belot, Lucie Obéric, et al.. (2022). Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial. Blood Advances. 6(24). 6169–6179. 8 indexed citations

Aide, Nicolas, Christophe Fruchart, Catherine Nganoa, Anne‐Claire Gac, & Charline Lasnon. (2020). Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy. European Radiology. 30(8). 4623–4632. 68 indexed citations

Morschhauser, Franck, Steven Le Gouill, Pierre Feugier, et al.. (2019). Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study. The Lancet Haematology. 6(8). e429–e437. 61 indexed citations

Gyan, Emmanuel, Anne Sonet, Pauline Brice, et al.. (2018). Bendamustine and rituximab in elderly patients with low‐tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study. British Journal of Haematology. 183(1). 76–86. 11 indexed citations

Aide, Nicolas, et al.. (2017). Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 45(5). 699–711. 39 indexed citations

Nganoa, Catherine, Anne‐Claire Gac, Christophe Fruchart, et al.. (2017). Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score. European Journal of Nuclear Medicine and Molecular Imaging. 45(6). 941–950. 13 indexed citations

Bonnet, Christophe, Thierry Lamy, Christophe Fruchart, et al.. (2016). Ibrutinib in Association with R-DHAP/Ox for Patients with Relapsed/Refractory B-Cell Lymphoma: Preliminary Results of the Biblos Phase Ib Lysa Study. Blood. 128(22). 5384–5384. 3 indexed citations

Quak, Elske, et al.. (2015). 18F-FDG PET/CT in Hepatosplenic Gamma-Delta T-Cell Lymphoma. Clinical Nuclear Medicine. 40(9). 730–731. 3 indexed citations

Fruchart, Christophe, Hervé Tilly, Franck Morschhauser, et al.. (2014). Upfront Consolidation Combining Yttrium-90 Ibritumomab Tiuxetan and High-Dose Therapy with Stem Cell Transplantation in Poor-Risk Patients with Diffuse Large B Cell Lymphoma. Biology of Blood and Marrow Transplantation. 20(12). 1905–1911. 11 indexed citations

10.

Delarue, Richard, Hervé Tilly, Nicolas Mounier, et al.. (2013). Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial. The Lancet Oncology. 14(6). 525–533. 205 indexed citations

11.

Marchand, Tony, Richard Lemal, Emmanuel Gyan, et al.. (2013). Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA. Annals of Oncology. 24(10). 2612–2618. 27 indexed citations

12.

Ketterer, Nicolas, Catherine Thiéblemont, Christophe Fermé, et al.. (2012). Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B). Annals of Oncology. 24(4). 1032–1037. 21 indexed citations

13.

Safar, Violaine, Jehan Dupuis, Emmanuel Itti, et al.. (2011). Interim [ ¹⁸ F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab. Journal of Clinical Oncology. 30(2). 184–190. 124 indexed citations

14.

Delarue, Richard, Corinne Haïoun, Florence Broussais‐Guillaumot, et al.. (2009). Efficacy and Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results of the Interim Analysis of the LNH03-6B GELA Study.. Blood. 114(22). 1701–1701. 2 indexed citations

15.

Bastard, Christian, Grégory Raux, Christophe Fruchart, et al.. (2007). Comparison of a quantitative PCR method with FISH for the assessment of the four aneuploidies commonly evaluated in CLL patients. Leukemia. 21(7). 1460–1463. 20 indexed citations

16.

Smadja, Nicole, Christian Bastard, Christophe Brigaudeau, Dominique Leroux, & Christophe Fruchart. (2001). Hypodiploidy is a major prognostic factor in multiple myeloma. Blood. 98(7). 2229–2238. 277 indexed citations

17.

Jardin, Fabrice, Aspasia Stamatoullas, Christophe Fruchart, et al.. (1999). Atteinte de la moelle épinière et envahissement méningé lors d'une maladie de Hodgkin. À propos d'un cas et revue de la littérature. La Revue de Médecine Interne. 20(3). 267–271. 11 indexed citations

18.

Stamatoullas, Aspasia, et al.. (1997). Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age. Bone Marrow Transplantation. 19(1). 31–35. 25 indexed citations

19.

Stamatoullas, Aspasia, Christophe Fruchart, Dominique Boulet, et al.. (1996). Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. Cancer. 77(11). 2302–2307. 21 indexed citations

20.

Fruchart, Christophe, Bernard Lenormand, Christian Bastard, et al.. (1996). Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia. American Journal of Hematology. 53(3). 175–180. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact